The pharma company said asundexian, when combined with antiplatelet therapy, lowered the risk of stroke in patients during the study.
In addition to reducing hunger, popular weight-loss drugs also affect reward processing and motivated behaviors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback